Shai Meretzki, PhD link

ShaiShai Meretzki, PhD - Chief Executive Officer and President 
Former founder, CEO and CTO of Pluristem Therapeutics Inc. (OTCBB: PSTI) a cell therapy company, Dr. Meretzki brings broad technical and managerial experience in the biotechnology discipline. Dr. Meretzki has vast experience in biological and chemical R&D, specifically in the area of cell culture, ex-vivo tissue engineering and bone regeneration.He holds PhD and MSc degrees in Biotechnology from the Technion - Israel Institute of Technology in cooperation with the Weizmann Institute, Israel. He also serves as Chairman of the Board at Biological Industries Israel Beit HaEmek Ltd.